ProtheraCytes®

About CellProthera

CellProthera is a clinical-stage biotech focused on autologous cell therapy for cardiac regeneration. Its core technology is a bioproduction platform that expands a patient's CD34+ stem cells, which are then re-injected to promote healing after a severe heart attack. The company has reported Phase I/IIb results and is advancing its lead program, having recently acquired a transendocardial catheter delivery system to enhance its therapeutic delivery. CellProthera represents a personalized medicine approach to addressing the significant unmet need in heart failure.

Therapeutic Areas